ANG Lifesciences Stock Screener | Share Price & Fundamental Analysis
ANG
Pharmaceuticals
Screen ANG Lifesciences share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹28.10
▲
0.04 (0.14%)
Market Cap
₹38.48 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.64
EPS (TTM)
₹-9.42
Dividend Yield
-
Debt to Equity
1.11
52W High
₹43.91
52W Low
₹21.64
Operating Margin
-4.00%
Profit Margin
-11.11%
Revenue (TTM)
₹18.00
EBITDA
-
Net Income
₹-2.00
Total Assets
₹230.00
Total Equity
₹64.00
ANG Lifesciences Share Price History - Stock Screener Chart
Screen ANG historical share price movements with interactive charts. Analyze price trends and patterns.
ANG Lifesciences Company Profile - Fundamental Screener
Screen ANG Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ANG shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE236W01016
ANG Lifesciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ANG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 230 | 242 | 278 | 291 |
| Current Assets | 161 | 173 | 183 | 193 |
| Fixed Assets | 57 | 58 | 88 | 93 |
| Liabilities | ||||
| Total Liabilities | 230 | 242 | 278 | 291 |
| Current Liabilities | 22 | 22 | 29 | 41 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 64 | 76 | 86 | 84 |
| Share Capital | 13 | 13 | 13 | 10 |
| Reserves & Surplus | 46 | 59 | 69 | 69 |
Screen ANG income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18 | 25 | 26 | 38 | 20 | 33 | 25 | 49 | 57 | 34 | 19 | 96 | 74 | 60 | 47 |
| Expenses | 18 | 24 | 26 | 36 | 20 | 31 | 27 | 50 | 50 | 32 | 21 | 83 | 62 | 50 | 44 |
| EBITDA | 0 | 1 | 0 | 2 | 0 | 3 | -2 | -1 | 7 | 2 | -2 | 13 | 12 | 10 | 3 |
| Operating Profit % | -4.00% | 3.00% | 0.00% | 4.00% | -9.00% | 7.00% | -9.00% | -26.00% | 12.00% | 5.00% | -10.00% | 13.00% | 16.00% | 16.00% | 6.00% |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 |
| Interest | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 3 | 3 | 4 |
| Profit Before Tax | -4 | -3 | -3 | -4 | -4 | -1 | -6 | -6 | 2 | -3 | -6 | 7 | 7 | 4 | -3 |
| Tax | -2 | -1 | 0 | 0 | -1 | 1 | -1 | -1 | 1 | 0 | 0 | 2 | 3 | 2 | -1 |
| Net Profit | -2 | -2 | -3 | -4 | -3 | -2 | -5 | -5 | 2 | -2 | -6 | 5 | 4 | 3 | -2 |
| EPS | -1.56 | -1.52 | -2.24 | -2.75 | -2.35 | -1.53 | -3.98 | -3.63 | 1.41 | -1.74 | -4.52 | 5.16 | 3.99 | 2.20 | -1.36 |
ANG Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen ANG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 0 | -10 | 26 | 25 |
| Investing Activities | -2 | 20 | -9 | -44 |
| Financing Activities | 2 | -10 | -17 | 20 |
| Net Cash Flow | 0 | 0 | 0 | 0 |
Screen ANG shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.11% | 26.11% | 26.18% | 25.62% | 25.48% | 25.45% | 25.92% | 26.13% |
| Other Holding | 3.29% | 3.29% | 3.21% | 3.78% | 3.92% | 3.95% | 3.48% | 3.27% |
| Shareholder Count | 6,508 | 6,400 | 6,273 | 6,868 | 6,631 | 6,468 | 6,517 | 7,163 |
ANG Lifesciences Dividend Screener - Share Yield Analysis
Screen ANG dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.00 | 1.33% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
ANG Lifesciences Index Membership - Market Screener Classification
Screen ANG by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
ANG Lifesciences Market Events Screener - Corporate Actions
Screen ANG market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.68% | ||
| Bonus | 1:1 | - | ||
| Annual General Meeting | NA | -8.62% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.04% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -3.93% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -5.27% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -5.83% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.04% |
| 2022-07-13 | 2022-07-14 | Bonus | 1:4 | 36.04% |
| 2021-11-02 | 2021-11-04 | Dividend | ₹ 1.00 /share | 47.69% |
| 2016-05-18 | 2016-05-18 | Change Of Name | NA | - |
ANG Lifesciences Competitors Screener - Peer Comparison
Screen ANG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 47.48 |
ANG Lifesciences Company Announcements - News Screener
Screen ANG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-08 | Closure of Trading Window | View |
| 2025-11-14 | Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025 | View |
| 2025-11-14 | Board Meeting Outcome for Board Meeting Outcome For To Consider And Approve The Financial Results For The Quarter And Half Year Ended 30-09-2025 | View |
| 2025-11-06 | Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September 2025. | View |
| 2025-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Appoitment Of Secretarial Auditor | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-12 | Clarification On Price Movement | View |
| 2025-09-12 | Clarification Sought from ANG Lifesciences India Ltd | - |
| 2025-09-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-06 | Notice Of 19Th AGM Of The Company Scheduled To Be Held On 30Th September 2025 | View |
| 2025-09-06 | Intimation Of Book Closure | View |
| 2025-09-06 | 19Th Annual General Meeting (AGM) Of The Shareholders Of The Company Will Be Held On Tuesday The 30Th September 2025 At 11:30 AM Through Video Conference (VC) / Other Audio Visual Means (OAVM) | View |
| 2025-09-06 | Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM | View |
| 2025-08-14 | Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30.06.2025. | View |
| 2025-08-14 | Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30 2025 | View |
| 2025-08-06 | Board Meeting Intimation for Conducting Board Meeting To Consider And Approve Unaudited Standalone & Consolidated Financial Results For The First Quarter Ended 30Th June 2025. | View |